Hormone replacement therapy and cardioprotection: basic concepts and clinical considerations (Q41461162)

1 October 2017

1 reference

title

Hormone replacement therapy and cardioprotection: basic concepts and clinical considerations (English)

1 reference

Hormone Replacement Therapy

1 October 2017

1 reference

Pines A

1

1 reference

1 October 2017

Mijatovic V

series ordinal

2

1 reference

1 October 2017

van der Mooren MJ

series ordinal

3

1 reference

1 October 2017

Kenemans P

series ordinal

4

1 reference

1 October 2017

1 February 1997

1 reference

European Journal of Obstetrics Gynecology and Reproductive Biology

1 October 2017

1 reference

1 October 2017

71

1 reference

1 October 2017

2

1 reference

1 October 2017

193-197

1 reference

Cardiovascular health and disease in women

1 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

Estrogen and coronary heart disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

Reduced mortality associated with long-term postmenopausal estrogen therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

Plasma homocysteine and menopausal status.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

Plasma levels of the atherogenic amino acid homocysteine in post-menopausal women with breast cancer treated with tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

Human vascular smooth muscle cells contain functional estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

Influence of sex hormones on plasma endothelin levels

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

Cardiovascular protection by oestrogen--a calcium antagonist effect?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

Increased synthesis of aortic collagen and elastin in experimental atherosclerosis. Inhibition by contraceptive steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

Effects of estradiol and progesterone on the increased synthesis of collagen in atherosclerotic rabbit aortas

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

Estrogens as natural antioxidants of membrane phospholipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

Exercise echocardiography in postmenopausal hormone users with mild systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

Postmenopausal use of estrogen and occlusion of coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

Risk factors and noncontraceptive estrogen use in women with and without coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

Cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902634-6

7 January 2021

10.1016/S0301-2115(96)02634-6

Identifiers

DOI

1 reference

1 October 2017

1 reference